Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Current Atherosclerosis Reports|December 21, 2000
ProbucolK D Pfuetze, C A Dujovne
Current Opinion in Lipidology|December 31, 1997
New lipid lowering drugs and new effects of old drugsC A Dujovne
The American Journal of Cardiology|May 15, 1997
The clinical therapeutic implications of the Scandinavian Simvastatin Survival StudyC A Dujovne
Clinical Cardiology|February 1, 1991
Drug intervention trials in dyslipidemia: the past and the futureC A Dujovne
Pharmacology & Therapeutics|August 1, 1994
Drug interactions with fibric acidsA Lozada, C A Dujovne
Pharmacology|January 1, 1980
Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systemsC A Dujovne, A S Salhab
Drugs in R&D|November 24, 1999
Lipid-altering drugs in developmentH E Bays, C A Dujovne
The American Journal of Medicine|June 6, 1994
Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacyC A Dujovne, M H Davidson
Drug Safety|November 24, 1998
Drug interactions of lipid-altering drugsH E Bays, C A Dujovne
Clinical Pharmacology and Therapeutics|February 1, 1980
Cholestyramine and spironolactone and their combination in digitoxin eliminationS G Carruthers, C A Dujovne
Pageof 7